Integrative genomic and transcriptomic analysis reveals immune subtypes and prognostic markers in ovarian clear cell carcinoma

被引：0
作者：
Shuang Ye
Qin Li
Yutuan Wu
Wei Jiang
Shuling Zhou
Xiaoyan Zhou
Wentao Yang
Xiaoyu Tu
Boer Shan
Shenglin Huang
Huijuan Yang
机构：
[1] Fudan University Shanghai Cancer Center,Department of Gynecologic Oncology
[2] Shanghai Medical College,Department of Oncology
[3] Fudan University,Fudan University Shanghai Cancer Center, and the Shanghai Key Laboratory of Medical Epigenetics
[4] Institutes of Biomedical Sciences,Department of Pathology
[5] Fudan University,undefined
[6] Fudan University Shanghai Cancer Center,undefined
来源：
British Journal of Cancer | 2022年 / 126卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1215 / 1223
页数：8
相关论文
共 228 条
[41]  
Zhong S(2018)Phase II study of single-agent cabozantinib in patients with recurrent clear cell ovarian, primary peritoneal or fallopian tube cancer (NRG-GY001) Gynecologic Oncol 150 undefined-undefined
[42]  
Shan B(2016)Predictive biomarkers for checkpoint inhibitor-based immunotherapy Lancet Oncol 17 undefined-undefined
[43]  
Zhou S(2021)Alterations in the RTK/Ras/PI3K/AKT pathway serve as potential biomarkers for immunotherapy outcome of diffuse gliomas Aging 13 undefined-undefined
[44]  
Wu X(undefined)undefined undefined undefined undefined-undefined
[45]  
Yang H(undefined)undefined undefined undefined undefined-undefined
[46]  
Ye S(undefined)undefined undefined undefined undefined-undefined
[47]  
Zhou S(undefined)undefined undefined undefined undefined-undefined
[48]  
Chen W(undefined)undefined undefined undefined undefined-undefined
[49]  
Xiang L(undefined)undefined undefined undefined undefined-undefined
[50]  
Wu X(undefined)undefined undefined undefined undefined-undefined
12345678910